Skip directly to content

Innovation in the UK

Our medicines save and transform the lives of millions of people in the UK every year.

Pfizer has a long and proud history of being part of world class science in the UK. From being the first company to mass produce penicillin back in the 1950’s, to the discovery of new treatments in important areas of unmet medical need including heart disease, HIV and acute pain.

We invest time, knowledge and money, working alongside the best of British science to find and develop new medicines and vaccines. Today, in addition to our research centres in Cambridge and Sandwich, we are involved in hundreds of research collaborations and alliances. By partnering with scientists, academics and clinicians throughout the UK, we are working to find the new medicines and vaccines of the future.

Our research activities here span more than 60 years. Over the last decade we have invested almost £3billion in UK research to develop the medicines and vaccines of the future for debilitating conditions including pain, cancer, diabetes, arthritis and Alzheimer’s.

Sandwich

For 60 years, Sandwich has been the home of Pfizer’s biggest research site in the UK. 

Part of the thriving Discovery Park site, Pfizer has played an important part in the development of a growing life sciences hub, including a range of smaller biotech companies and start-ups.

It also plays an important role in developing Pfizer’s future pipeline as the home of our Pharmaceutical Sciences team.

This team uses its specialist expertise to turn experimental new compounds into the liquid and solid dose medicines that can be used in clinical trials, and latterly given to patients more broadly.

The capabilities we have to do this at Sandwich are unique – it is the only site within Pfizer’s R&D network able to perform every step in the complex process of producing a new medicine.

What’s more, the site is home to Pfizer’s only fully automated Pilot Plant that manufactures medicines for use in Pfizer’s clinical trials worldwide.

Additionally, Sandwich hosts Pfizer’s Worldwide Safety and Regulatory (WSR) group. Working closely with colleagues in nearly every country across the world, this team creates the regulatory submissions needed for every medicine in Pfizer’s portfolio as well as monitoring patterns of adverse events reported by patients and reviewing safety information.

  

DCOM0011/Date of preparation: May 2015